Johnson & Johnson: Nervous illness after vaccination

Johnson & Johnson’s corona vaccine has had a bad reputation in the United States so far. After possible sinus vein thrombosis was associated with the vaccine, the American Food and Drug Administration (FDA) warns of a nervous disease.

The risk of developing the dangerous nervous disease, the so-called Guillain-Barré syndrome, is low, but a connection is possible.

Guillain-Barré syndrome and Johnson & Johnson: mostly in men

The FDA issued a warning Monday regarding the nervous disorder. Together with the American health authority CDC, 100 cases are being reviewed. Those affected contracted Guillain-Barré syndrome shortly after being vaccinated with the single-use vaccine from Johnson & Johnson. So far one death is known, most of the sick people were men.

So far it has not been proven whether the vaccine is the cause of the disease. According to estimates by the CDC, around 3,000 to 6,000 people in the USA suffer from the nervous disease. The triggers include the flu and the  Zika virus .

 Cases of Guillain-Barré syndrome have also been observed after infection with the  coronavirus .

Nerve Disease: Symptoms of Guillain-Barré Syndrome (GBS)

GBS is acute or subacute inflammation of the spinal cord and peripheral nerves. It occurs 75 percent after infections, but vaccinations can also be a trigger. GBS leads to neuromuscular disorders.

Common symptoms of Guillain-Barré syndrome are:

  • sudden weakness
  • numbness
  • Tingling, pins and needles, or prickling in the extremities
  • local pains in the extremities

Patients with these symptoms should be observed in the hospital.


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *